- Waldenström Macroglobulinemia
- Melanoma
- Bladder Cancer
- Brain Cancer
- Breast Cancer
- Childhood Cancers
- Gastric Cancer
- Gynecologic Cancer
- Head & Neck Cancer
- Immunotherapy
- Kidney Cancer
- Leukemia
- Liver Cancer
- Lung Cancer
- Lymphoma Cancer
- Mesothelioma
- MPN
- MDS
- Myeloma
- Prostate Cancer
- Rare Cancers
- Sarcoma
- Skin Cancer
- Testicular Cancer
- Thyroid Cancer
Lee Schwartzberg on Nausea Concerns for Newly Diagnosed Patients
Lee Schwartzberg, executive director of the University of Tennessee West Cancer Center, discusses concerns that patients newly diagnosed with cancer have about chemotherapy-induced nausea and vomiting (CINV).
Lee Schwartzberg, executive director of the University of Tennessee West Cancer Center, discusses concerns that patients newly diagnosed with cancer have about chemotherapy-induced nausea and vomiting (CINV).
Schwartzberg said that many patients fear that they will be sick for days after getting chemotherapy, though those concerns are no longer warranted thanks to the variety of different medicines available to treat nausea and vomiting. But while the majority of patients do not get sick, some still do, creating an unmet need in oncology.
Traditional Definition of ‘High-Risk’ in Patients With CLL and SLL Outdated, Needs to be Revisited
December 7th 2020In an interview with CURE®, Dr. Jan A. Burger discusses how the results of two phase 3 studies could help redefine what constitutes as low or high risk in patients with CLL or SLL.
Read More
To gain a better understanding of the issues faced by geriatric patients with cancer, and to determine how much of a role nutrition plays in outcomes, Dr. Grant Williams, a geriatrician oncologist and assistant professor at the University of Alabama, Birmingham, worked with colleagues to create a patient-reported assessment tool that bridges the knowledge gap in this patient population.
Read More
